Table 5.
Etiological Patterns of Bacteremia Among Febrile Children with Sickle Cell Anemia (N = 209)
| Antibiotic | Staphylococcus aureus 25(56.8) | Escherichia coli 8(18.2%) |
Klebsiella pneumoniae 3(6.8%) |
Haemophilus influenzae 3(6.8%) |
Coagulase Negative Staphylococcus 2(4.5%) | Streptococcus pneumoniae 2(4.5%) |
Salmonella typhi 1(2.3%) |
|
|---|---|---|---|---|---|---|---|---|
| Meropenem | S | 100.0% | 100.0% | 100.0% | 100.0% | |||
| Imipenem | S | 100.0% | ||||||
| Nitrofurantoin | S | 100.0% | 100.0% | |||||
| Vancomycin | S | 100.0% | 100.0% | |||||
| Cloxacillin | S | 100.0% | 100.0% | |||||
| Cefotaxime | S | 100.0% | 100.0% | 100.0% | ||||
| Cefepime | S | 33.3% | 100.0% | |||||
| I | 66.7% | |||||||
| Levofloxacin | S | 100.0% | ||||||
| I | 100.0% | 100.0% | ||||||
| Cefixime | S | 40.0% | ||||||
| I | 60.0% | |||||||
| Ceftriaxone | S | 40.0% | 100.0% | |||||
| I | 10.0% | 100.0% | ||||||
| R | 90.0% | 60.0% | ||||||
| Ciprofloxacin | S | 15.4% | 100.0% | |||||
| I | 61.5% | 50.0% | ||||||
| R | 23.1% | 50.0% | ||||||
| Amikacin | S | 38.5% | 100.0% | 100.0% | ||||
| I | 30.8% | |||||||
| R | 30.8% | |||||||
| Chloramphenicol | S | 25.0% | 100.0% | 100.0% | 100.0% | 100.0% | ||
| I | 50.0% | |||||||
| R | 25.0% | 100.0% | ||||||
| Cefoxitin | S | 50.0% | ||||||
| R | 50.0% | |||||||
| Cotrimoxazole | S | 100.0% | 100.0% | |||||
| R | 100.0% | 100.0% | ||||||
| Cephalexin | I | 100.0% | 100.0% | |||||
| Piperacillin | I | 100.0% | ||||||
| Clarithromycin | I | 100.0% | 100.0% | 100.0% | ||||
| Cefazolin | I | 100.0% | ||||||
| Cefuroxime | I | 100.0% | 100.0% | |||||
| Erythromycin | I | 100.0% | ||||||
| Clindamycin | I | 100.0% | ||||||
| R | 100.0% | |||||||
| Ceftazidime | I | 66.7% | ||||||
| R | 33.3% | 100.0% | ||||||
| Gentamicin | R | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Ampicillin | R | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Penicillin | R | 100.0% | 100.0% | |||||
| Ofloxacin | R | 100.0% |